Clinical trial

BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics

NCT03540615

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-06-28

PhasePHASE1

Study timeline

Study start (actual)2018-06-28Date precision: day

Registry last updated2020-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritis, Rheumatoidunresolved

Interventions

BAY1830839DRUG

PlaceboDRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03540615 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.